Nasus Pharma Ltd. (NYSEAMERICAN:NSRX – Get Free Report) was up 5.1% during mid-day trading on Monday . The stock traded as high as $3.18 and last traded at $3.08. Approximately 15,893 shares were traded during mid-day trading, a decline of 24% from the average daily volume of 20,913 shares. The stock had previously closed at $2.93.
Analyst Ratings Changes
Separately, Citizens Jmp dropped their price target on shares of Nasus Pharma from $19.00 to $18.00 and set a “market outperform” rating for the company in a research note on Thursday, March 26th. One equities research analyst has rated the stock with a Buy rating, Based on data from MarketBeat, the company presently has an average rating of “Buy” and a consensus price target of $18.00.
Get Our Latest Research Report on Nasus Pharma
Nasus Pharma Stock Up 5.1%
About Nasus Pharma
Nasus Pharma Ltd. is a clinical-stage pharmaceutical company focused on the development of innovative intranasal products to treat emergency medical conditions. Nasus Pharma Ltd. is based in TEL AVIV, Israel.
Recommended Stories
- Five stocks we like better than Nasus Pharma
- The SK Hynix IPO and 2027’s AI Memory Squeeze
- Meta Platforms Stock Rises as Muse Spark 1.1 AI Model Debuts
- Why Welltower’s Growth Story Might Outrun Its Rich Valuation
- One Short- and One Long-Term ETF for Quantum Computing Bulls
Receive News & Ratings for Nasus Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nasus Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
